Profile data is unavailable for this security.
About the company
Biotechnology Assets SA, formerly known as ADL Bionatur Solutions SA, is a Spain-based biotech company. The Company's main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company's purpose is the acquisition and promotion of real estate of an urban nature for lease through the ownership of assets directly, through companies with this purpose, with the holding of shares in the capital of other entities, resident or not in the Spanish territory, or through collective investment vehicles.
- Revenue in EUR (TTM)2.61m
- Net income in EUR-2.08m
- Incorporated2005
- Employees30.00
- LocationBiotechnology Assets SAAv. del Desarrollo Tecnologico, 11JEREZ DE LA FRONTERA 11591SpainESP
- Phone+34 856060603
- Fax+34 956876851
- Websitehttps://biatgroup.com/es/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exact Therapeutics AS | 0.00 | -6.38m | 10.90m | 12.00 | -- | 1.82 | -- | -- | -1.40 | -1.40 | 0.00 | 1.07 | 0.00 | -- | -- | 0.00 | -108.82 | -43.50 | -168.39 | -50.76 | -- | -- | -- | -- | -- | -20.18 | 0.0052 | -- | -- | -- | -8.27 | -- | 1.47 | -- |
| Abera Bioscience AB | 0.00 | -137.17k | 11.16m | 5.00 | -- | 4.21 | -- | -- | -0.0872 | -0.0872 | 0.00 | 1.51 | 0.00 | -- | -- | 0.00 | -6.61 | -68.96 | -7.94 | -85.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 93.42 | -- | -- | -- |
| Alzinova AB | 19.34k | -2.54m | 11.62m | 5.00 | -- | 0.6022 | -- | 600.90 | -0.2846 | -0.2846 | 0.0022 | 1.23 | 0.0015 | -- | 0.3254 | 41,000.00 | -19.42 | -12.21 | -20.69 | -12.85 | -5,834.15 | -- | -13,114.15 | -21,390.81 | -- | -1,794.80 | 0.0062 | -- | -88.89 | -- | -24.71 | -- | 19.48 | -- |
| Sds Optic SA | 1.77m | -114.83k | 11.97m | 41.00 | -- | 51.32 | 228.83 | 6.77 | -0.0815 | -0.0815 | 1.25 | 0.1559 | 0.5497 | 5.12 | 125.84 | 181,486.60 | -4.01 | -32.89 | -4.24 | -41.35 | 98.19 | 49.49 | -7.29 | -136.62 | 2.50 | 0.6278 | 0.00 | -- | 40.53 | 301.05 | -45.06 | -- | 57.27 | -- |
| Addex Therapeutics Ltd | 607.93k | -6.35m | 11.97m | 2.00 | -- | 0.9782 | -- | 19.69 | -0.0565 | -0.0555 | 0.0054 | 0.0511 | 0.057 | -- | 1.96 | 277,600.00 | -59.51 | -72.61 | -66.55 | -93.27 | -- | -- | -1,045.06 | -535.67 | -- | -0.5606 | 0.0061 | -- | -74.64 | -32.06 | -96.36 | -- | -46.31 | -- |
| Celyad Oncology SA | 186.00k | -6.46m | 12.18m | 12.00 | -- | -- | -- | 65.46 | -0.1558 | -0.1558 | 0.0045 | -0.0749 | 0.0201 | -- | 3.80 | 15,500.00 | -69.62 | -42.66 | -104.04 | -53.33 | 94.09 | 72.35 | -3,470.43 | -33,762.12 | 0.5921 | -257.64 | -- | -- | 82.35 | 98.73 | 31.06 | -- | -28.28 | -- |
| Predilife SA | 728.07k | -3.80m | 12.42m | 27.00 | -- | -- | -- | 17.06 | -0.9936 | -0.9936 | 0.1905 | -1.26 | 0.3919 | -- | 3.63 | 36,421.71 | -204.34 | -93.24 | -- | -132.80 | 98.10 | 89.32 | -521.48 | -1,377.00 | -- | -19.99 | -- | -- | 55.20 | 84.82 | -0.9621 | -- | -24.35 | -- |
| Sygnis SA | 1.84m | -1.51m | 12.76m | 12.00 | -- | 1.67 | -- | 6.95 | -0.2499 | -0.2499 | 0.3309 | 1.17 | 0.1166 | -0.1689 | 6.14 | 218,427.70 | -9.03 | -8.61 | -15.00 | -12.10 | 108.49 | 59.85 | -77.44 | -39.14 | 0.6697 | -0.0066 | 0.13 | -- | -52.29 | 26.88 | -47.44 | -- | -9.50 | -- |
| SoftOx Solutions AS | 1.20m | -264.82k | 12.91m | 5.00 | -- | 1.35 | 181.44 | 10.75 | -0.001 | -0.001 | 0.0065 | 0.0445 | 0.123 | -- | 30.13 | 2,717,798.00 | -2.72 | -50.91 | -3.22 | -67.07 | -- | -- | -22.07 | -644.92 | 1.16 | -3.92 | 0.1212 | -- | 13.38 | 14.06 | -8.86 | -- | -- | -- |
| Biotechnology Assets SA | 2.61m | -2.08m | 13.91m | 30.00 | -- | 2.01 | -- | 5.33 | -0.0363 | -0.0363 | 0.0436 | 0.0948 | 0.1833 | -- | 1.15 | 76,815.59 | -14.59 | -6.21 | -18.75 | -8.65 | 82.09 | 67.88 | -79.60 | -55.83 | -- | -5.92 | 0.2384 | -- | -30.18 | 3.38 | -285.37 | -- | -37.38 | -- |
| Nfl Biosciences SAS | 0.00 | -3.15m | 13.96m | 4.00 | -- | 4.08 | -- | -- | -0.2779 | -0.2779 | 0.00 | 0.2699 | 0.00 | -- | -- | 0.00 | -66.86 | -75.08 | -91.01 | -121.22 | -- | -- | -- | -- | -- | -- | 0.0088 | -- | -- | -- | 44.44 | -- | -- | -- |
| NextCell Pharma AB | 1.03m | -3.32m | 14.92m | 24.00 | -- | 2.38 | -- | 14.46 | -0.4414 | -0.4414 | 0.133 | 0.596 | 0.1384 | 51.23 | 4.68 | -- | -44.48 | -34.95 | -49.25 | -37.53 | -155.37 | -266.34 | -321.31 | -427.08 | 9.92 | -- | -- | -- | 2.56 | 25.13 | 16.25 | -- | 36.88 | -- |
| Poxel SA | 7.66m | -13.66m | 15.16m | 5.00 | -- | -- | -- | 1.98 | -0.2594 | -0.2594 | 0.1443 | -1.14 | 1.45 | -- | 8.90 | 1,276,167.00 | -258.08 | -69.11 | -- | -133.51 | 52.02 | 80.83 | -178.45 | -475.98 | -- | -0.1862 | -- | -- | 234.98 | -24.22 | 47.83 | -- | -- | -- |
| Read Gene SA | 3.61m | -210.68k | 15.62m | 11.00 | -- | 24.55 | -- | 4.33 | -0.0536 | -0.0536 | 1.17 | 0.2273 | 1.08 | 39.77 | 6.30 | -- | -6.32 | -2.40 | -6.88 | -2.74 | 92.63 | 90.21 | -5.84 | -4.30 | 6.31 | -0.696 | 0.00 | -- | 30.38 | 26.38 | 17.49 | -- | -- | -- |
| ViroGates A/S | 675.15k | -1.66m | 16.35m | 7.00 | -- | 35.88 | -- | 24.21 | -1.63 | -1.63 | 0.6609 | 0.3665 | 0.3568 | 0.9777 | 4.41 | 504,300.00 | -87.63 | -54.92 | -131.36 | -63.15 | 47.33 | 72.98 | -245.63 | -215.48 | 1.58 | -16.13 | 0.6277 | -- | -12.27 | 6.45 | -18.59 | -- | -- | -- |
| SenzaGen AB | 5.46m | -1.53m | 16.53m | 37.00 | -- | 2.36 | -- | 3.03 | -0.5483 | -0.5483 | 1.96 | 2.52 | 0.5577 | 5.47 | 6.63 | 1,702,294.00 | -15.59 | -20.91 | -18.89 | -25.17 | 65.09 | 67.10 | -27.95 | -71.43 | 2.73 | -- | 0.0707 | -- | 15.69 | 84.16 | 19.22 | -- | -1.18 | -- |
Data as of Feb 13 2026. Currency figures normalised to Biotechnology Assets SA's reporting currency: Euro EUR
0.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GVC Gaesco Gesti�n SGIIC SAas of 31 Dec 2025 | 70.45k | 0.10% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
